对HbSC疾病和其他复合异合体状血红蛋白病的基因疗法:纳入的时间
Andrew Wilks1, Martin H Steinberg2, Haydar Frangoul3
1Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States.
Blood
|August 20, 2025
概括
基因疗法为状细胞疾病 (SCD) 提供了潜在的治疗方法. 本综述探讨了它在常见的SCD基因型HbSC疾病中的应用,并讨论了胎儿血红蛋白如何减轻并发症.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 医学遗传学 医学遗传学
背景情况:
- 两种基因疗法被FDA批准用于状细胞疾病 (SCD),主要用于状细胞贫血和HbS-β0血症.
- HbSC疾病,SCD的复合异合体形式,是第二个最常见的基因型.
- 基因疗法尚未在严重症状的HbSC疾病患者中进行评估.
研究的目的:
- 审查HbSC疾病的病理生理学和临床特征.
- 讨论基因治疗作为治疗HbSC疾病的治疗选择的潜力.
- 探索胎儿血红蛋白 (HbF) 和类似HbF的HbA (HbAT87Q) 可能减少SCD的不良结果的机制.
主要方法:
- 文献综述和对SCD,HbSC疾病和基因治疗现有研究的综合.
- 对HbSC疾病特有的病理生理学和临床表现的分析.
- 讨论HbF和HbAT87Q在缓解SCD并发症方面的潜在治疗机制.
主要成果:
- HbSC疾病具有独特的临床和病理生理学特征.
- 基因疗法作为选择HbSC疾病患者的治愈治疗具有前景.
- 升高的HbF或HbAT87Q水平可能会改善SCD的临床严重程度和末端器官损伤.
结论:
- 基因疗法是HbSC疾病的潜在治疗方法.
- 了解HbF和HbAT87Q机制可以为未来的SCD治疗策略提供信息.
- 需要进一步的研究来评估HbSC疾病群体的基因疗法.
相关概念视频
Multiple Allele Traits
34.8K
The Concept of Multiple Allelism
34.8K
Gene Therapy
25.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.8K
Hemoglobin
4.4K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
4.4K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Disorders of Erythrocytes
1.2K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.2K


